11293003

Kalro BN

2001

Neuromodulation in polycystic ovary syndrome.

11293004

Moran C

2001

The role of the adrenal cortex in polycystic ovary syndrome.

11293005

Bracero N

2001

Polycystic ovary syndrome and hyperprolactinemia.

11293006

Hoeger K

2001

Obesity and weight loss in polycystic ovary syndrome.

11293007

Legro RS

2001

Diabetes prevalence and risk factors in polycystic ovary syndrome.

11293919

Mart?nez-Guisasola J

2001

Plasma beta-endorphin levels in obese and non-obese patients with polycystic ovary disease.

11294032

Ter?n D?vila J

2001

[Polycystic ovary syndrome of extra-ovarian origin. Review].

11295565

Stapley L

2001

PCOS and an increased risk of type 2 diabetes mellitus.

11297583

Obiezu CV

2001

Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome.

11297588

Elting MW

2001

The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries.

11297595

Azziz R

2001

Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.

11304880

Notelovitz M

2001

Effects of estrogen/androgen therapy on bone mineral density parameters.

11310177

Peters AL

2001

Using thiazolidinediones: rosiglitazone and pioglitazone in clinical practice.

11313523

Dhanwal D

2001

Isolated menarche and multicystic ovaries in a 7 1/2 year girl with hypothyroidism.

11318779

Pirwany IR

2001

Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.

11318780

Dejager S

2001

Smaller LDL particle size in women with polycystic ovary syndrome compared to controls.

11319503

Iurassich S

2001

[Correlations between acne and polycystic ovary. A study of 60 cases].

11327649

Tebble JE

2001

Ultrasound diagnosis and treatment outcome of cystic ovaries in cattle.

11331217

Kowalska I

2001

Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome.

11331641

Cibula D

2001

Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?

11334897

Heinonen S

2001

Apolipoprotein E alleles in women with polycystic ovary syndrome.

11334898

Padmanabhan V

2001

Dynamics of bioactive follicle-stimulating hormone secretion in women with polycystic ovary syndrome: effects of estradiol and progesterone.

11334920

Calvo RM

2001

Role of the follistatin gene in women with polycystic ovary syndrome.

11335776

Freemark M

2001

The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.

11337921

Vasiljevi? M

2000

[Synthesis and secretion of ovarian steroid hormones in polycystic ovary syndrome].

11344202

Colilla S

2001

Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives.

11344938

Speiser PW

2001

Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.

11355746

Cizza G

2001

Circulating plasma leptin and IGF-1 levels in girls with premature adrenarche: potential implications of a preliminary study.

11360636

Tao Y

1999

[Treatment of polycystic ovary syndrome and related infertility with clomiphene resistance by compound cyproterone acetate].

11372403

Li M

2000

[Current status of study on polycystic ovary syndrome].

11372404

Mao W

2000

[Study on parents phenotypes in women with polycystic ovary syndrome].

11372405

Li X

2000

[Changes of plasma renin activity and angiotensin II levels in women with polycystic ovary syndrome].

11372406

Chen W

2000

[Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].

11372407

Liang X

2000

[Treatment options of clomiphene-resistant polycystic ovary syndrome related infertility].

11372408

Wang Y

2000

[Congression and regression tree analyses on the outcome of ovulation induction in women with polycystic ovary syndrome].

11372809

Elliott JL

2001

Endometrial adenocarcinoma and polycystic ovary syndrome: risk factors, management, and prognosis.

11375369

Peppard HR

2001

Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes.

11375796

Vrb?kov? J

2001

The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome.

11379008

Marszalek B

2001

Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'-UTR in patients with polycystic ovarian syndrome.

11379011

Loverro G

2001

Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow.

11383926

Tong Y

2001

Absence of mutations in the coding regions of follicle-stimulating hormone receptor gene in Singapore Chinese women with premature ovarian failure and polycystic ovary syndrome.

11384638

Marci R

2001

A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins.

11384640

Heider U

2001

Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries.

11384661

Kim NK

2001

The luteinizing hormone beta-subunit exon 3 (Gly102Ser) gene mutation is rare in Korean women with endometriosis and polycystic ovary syndrome.

11385092

Blackwell VC

2001

Partial lipodystrophy, polycystic ovary syndrome and proteinuria: a common link to insulin resistance?

11387269

Bergendah M

2001

Is there a physiological role for gonadotrophin oligosaccharide heterogeneity in humans? III. Luteinizing hormone heterogeneity: a medical physiologist's perspective.

11387273

Fedorcs?k P

2001

The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome.

11387301

Kirchengast S

2001

Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome.

11388600

Satoh M

2001

Two hyperandrogenic adolescent girls with congenital portosystemic shunt.

11396371

Ushiroyama T

2001

Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion.

11396658

Norman RJ

2001

Obesity, polycystic ovary syndrome and anovulation--how are they interrelated?

11397835

Gill S

2001

Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.

11397838

Kelly CC

2001

Low grade chronic inflammation in women with polycystic ovarian syndrome.

11397848

Azziz R

2001

Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin.

11397859

Koivunen RM

2001

Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes.

11406034

Bayram N

2001

Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome.

11410072

Marshall K

2001

Polycystic ovary syndrome: clinical considerations.

11411312

Krishna A

2001

Increase in calcitonin gene related peptide (CGRP) and decrease in mast cells in dihydroepiandrosterone (DHEA)-induced polycystic rat ovaries.

11412704

Estopi??n Garc?a V

2001

[Prolactin and polycystic ovary syndrome].

11423899

Sobande AA

2000

Ovarian hyperstimulation syndrome and deep vein thrombosis.

11425810

Spritzer PM

2001

Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements.

11425813

Laven JS

2001

Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility.

11425833

Lunde O

2001

Polycystic ovarian syndrome: a follow-up study on fertility and menstrual pattern in 149 patients 15-25 years after ovarian wedge resection.

11425842

ESHRE Capri Workshop Group.

2001

Ovarian and endometrial function during hormonal contraception.

11425843

Kashyap S

2001

Obstetric outcome in women with polycystic ovarian syndrome.

11426241

Abdul Salam MN

2001

Hope for clomiphene citrate resistant ovaries.

11427921

Zhdanov AV

2001

Suppressed production of transforming growth factor-beta(2)mRNA in endometrium of women with polycystic ovary syndrome.

11431640

De Conciliis B

2001

[Effects of metformin on insulin resistance and on ovarian steroidogenesis in women with polycystic ovary syndrome].

11437623

Betts T

2001

Epilepsy and the ovary (cutting out the hysteria).

11437624

Betts T

2001

Case reports.

11440917

Dunaif A

2001

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).

11442143

Genton P

2001

On the association between valproate and polycystic ovary syndrome.

11442144

Isoj?rvi JI

2001

On the association between valproate and polycystic ovary syndrome: a response and an alternative view.

11442145

Herzog AG

2001

Valproate and the polycystic ovarian syndrome: final thoughts.

11443148

Joffe H

2001

Polycystic ovarian syndrome--relationship to epilepsy and antiepileptic drug therapy.

11443149

Bilo L

2001

Characterization of reproductive endocrine disorders in women with epilepsy.

11445443

Abdu TA

2001

Endothelial dysfunction in endocrine disease.

11447727

Avvad CK

2001

Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence.

11447730

Wang Y

2001

Simplification of continuous infusion of glucose with model assessment in the evaluation of insulin resistance in women with PCOS.

11447731

Muneyyirci-Delale O

2001

Divalent cations in women with PCOS: implications for cardiovascular disease.

11447737

Cobellis L

2001

Regression of ovarian enlargement in pharmacological ovulation induction.

11448019

Y?ksel O

2001

Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome.

11451562

Guvenal T

2001

Unilateral massive ovarian edema and polycystic ovaries. A case report.

11452217

Bringer J

2001

[Insulin sensitivity and polycystic ovarian syndrome].

11452221

Girard J

2001

[Mechanisms of action of thiazolidinediones].

11453273

Williamson K

2001

The impact of ethnicity on the presentation of polycystic ovarian syndrome.

11453323

Lobo RA

2001

Priorities in polycystic ovary syndrome.

11453331

Norman RJ

2001

Metformin and intervention in polycystic ovary syndrome. Endocrine Society of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group.

11460095

Ghanaati Z

1999

Endocrinological and genetic studies in patients with Polycystic Ovary Syndrome (PCOS).

11467345

Sood V

2000

Thiazolidinediones: a comparative review of approved uses.

11469814

Walker BR

2001

Steroid metabolism in metabolic syndrome X.

11473949

Maliqueo M

2001

Resumption of ovarian function during lactational amenorrhoea in breastfeeding women with polycystic ovarian syndrome: metabolic aspects.

11473950

Sir-Petermann T

2001

Resumption of ovarian function during lactational amenorrhoea in breastfeeding women with polycystic ovarian syndrome: endocrine aspects.

11473953

Ng EH

2001

Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial.

11473967

Chian RC

2001

Pregnancy and delivery after cryopreservation of zygotes produced by in-vitro matured oocytes retrieved from a woman with polycystic ovarian syndrome.

11473970

Mikkelsen AL

2001

Morphology of in-vitro matured oocytes: impact on fertility potential and embryo quality.

11476353

Franks S

2001

Candidate genes in polycystic ovary syndrome.

11476780

Fulghesu AM

2001

A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio.

11477807

Cao Y

1999

[Progresses in the study of hereditary factors of polycystic ovarian syndrome].

11479944

Chen Y

1999

[Expression of apoptosis regulatory protein bcl-2 and bax in endometrium of polycystic ovary syndrome].